Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

4.69
+1.0629.20%
Post-market: 4.69-0.00010.00%19:59 EDT
Volume:355.37K
Turnover:1.57M
Market Cap:7.00M
PE:-2.17
High:5.06
Open:3.50
Low:3.43
Close:3.63
Loading ...

Berenberg Bank Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
22 Jul

Berenberg Bank Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
15 Jul

J.P. Morgan Sticks to Their Hold Rating for 888 Holdings (EVOK)

TIPRANKS
·
10 Jul

Evoke Pharma Surges on Notice of Patent Allowance for Gimoti

Dow Jones
·
10 Jul

Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May

Benzinga
·
09 Jul

Evoke Pharma receives notice of allowance for use of GIMOTI from USPTO

TIPRANKS
·
09 Jul

Evoke Pharma Secures Patent for GIMOTI Treatment

TIPRANKS
·
09 Jul

Evoke Pharma Granted Notice of Allowance for GIMOTI® Patent, Extending Market Exclusivity to 2036

Reuters
·
09 Jul

Evoke Pharma Holds Annual Meeting via Webcast

TIPRANKS
·
23 May

Evoke Pharma Inc. Conducted Annual Remote Meeting via Webcast

Reuters
·
23 May

Evoke Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Evoke Pharma Q1 Operating Expenses USD 4.4 Million

Reuters
·
14 May

Evoke Pharma Q1 EPS $(0.51) Misses $(0.33) Estimate, Sales $3.08M Miss $3.32M Estimate

Benzinga
·
14 May

Evoke Pharma Inc. Reports 77% Increase in Q1 2025 Net Product Sales to $3.1 Million; Operating Expenses Rise to $4.4 Million

Reuters
·
14 May

Evoke Pharma Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
09 May

Jefferies Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
01 Apr

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates

Simply Wall St.
·
16 Mar

Evoke Pharma’s Earnings Call Highlights Revenue Growth and Strategic Partnerships

TIPRANKS
·
15 Mar

Evoke Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Mar

Q4 2024 Evoke Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Mar